In addition to SCCHN, WHSC1L1 is frequently amplified in human breast cancer cell lines [14] and in 13% of breast cancer samples [3, 4], and high WHSC1L1 mRNA levels have been associated with worse survival in breast cancer patients [15]. Here, NSD3 is linked to breast carcinoma.